UPDATE 1-Loxo, Illumina to partner for diagnostic tool targeting cancer

April 10 (Reuters) - Drug developer Loxo Oncology said on Tuesday it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.